Health News (Reuters)

WHO says Congo faces 'very high' risk from Ebola outbreak

GENEVA (Reuters) - Democratic Republic of Congo faces a "very high" public health risk from Ebola after the disease was confirmed in one patient in a major city, the World Health Organization said on Friday, raising its assessment from "high" previously.

Early puberty in girls tied to bullying in school

(Reuters Health) - Girls who go through puberty early may be more likely than peers who mature later to be involved in bullying at school - either as victims or perpetrators, a recent study suggests.

Congo and WHO race to prevent runaway Ebola outbreak

KINSHASA (Reuters) - Congolese and U.N. officials were racing on Thursday to prevent a runaway Ebola outbreak in Congo, working out the logistics of keeping newly arrived vaccines well below freezing in a steamy region on the equator with unreliable power.

Reporting outcomes of PCI may not improve care

(Reuters Health) - Public reporting of outcomes for percutaneous coronary intervention (PCI) was supposed to improve quality, but some doctors say it hasn't delivered on the goal of enhancing patient care.

Florida officials probe cause of fatal vape device explosion

(Reuters) - Fire investigators are examining whether the battery in an electronic cigarette triggered a small explosion that killed a man in Florida this month, sending fragments of the vape device into his skull, in what may be the first such fatality in the country.

FDA names drugmakers potentially acting to delay cheap generics

(Reuters) - The U.S. Food and Drug Administration on Thursday listed drugmakers, including Celgene Corp , Johnson & Johnson , Gilead Sciences and Novartis AG , who the regulator says are potentially blocking access to samples of their drugs to delay generic competition.

Beer is not beneficial, German court rules

BERLIN (Reuters) - Beer cannot be marketed as beneficial, a German top court ruled on Thursday after a consumer rights group sued a brewery on the basis that its advertisement falsely suggested the beer had health benefits.

Mental health support lacking in U.S. diabetes care

(Reuters Health) - Most of the top diabetes treatment centers in the U.S. provide experts in hormonal disease, diet and nutrition and diabetes education as part of normal care, but mental health support is still not standard, researchers say.

U.N. staff on way to Congo to get experimental Ebola vaccine

LONDON (Reuters) - World Health Organization and other United Nations staff going to the Democratic Republic of Congo as emergency responders to an Ebola outbreak are being offered an unlicensed vaccine as protection before they go.

WHO calls emergency meeting on Congo's Ebola outbreak

GENEVA (Reuters) - The U.N. World Health Organization will convene an Emergency Committee on Friday to consider the international risks of an Ebola outbreak in the Democratic Republic of Congo, WHO spokesman Christian Lindmeier said on Thursday.

Congo health minister says Ebola outbreak in "new phase" after urban case

KINSHASA (Reuters) - Congo Health Minister Oly Ilunga Kalenga late on Wednesday said in a statement that the country's Ebola outbreak had entered "a new phase" after a case of the virus was detected in the northwest city of Mbandaka, with a population of about 1 million people.

FDA says harvest season over for E. coli-linked romaine lettuce

(Reuters) - The U.S. Food and Drug Administration said on Wednesday the harvest season for romaine lettuce, linked to the multi-state E. coli outbreak, was over and it was unlikely that it was still available in stores due to its 21-day shelf life.

Roche immunotherapy combination increases lung cancer survival - study

(Reuters) - Roche's immunotherapy Tecentriq, given with its older drug Avastin and chemotherapy, improved survival of advanced lung cancer patients by about 30 percent over the combination without Tecentriq, according to interim results of a late stage trial released on Wednesday.

Walgreen, Kroger, Albertsons, HEB sue Allergan over dry-eye drug

NEW YORK (Reuters) - Allergan Inc was sued on Wednesday by four large U.S. retailers that accused the drugmaker of antitrust violations for trying to stop rivals from selling generic versions of Restasis, its medication to treat dry-eye disease.